Literature DB >> 13608362

Studies on new diuretic compounds: spirolactone and chlorothiazide.

E BOLTE, M VERDY, J MARC-AURELE, J BROUILLET, P BEAUREGARD, J GENEST.   

Abstract

Entities:  

Keywords:  ACETAZOLAMIDE/related compounds; ALDOSTERONE/antagonists; DIURETICS/therapeutic use; HYPERTENSION/therapy

Mesh：

Substances：

Year:  1958        PMID： 13608362      PMCID： PMC1830510     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Chlorothiazide potentiation of ganglionic blockade in patients with hypertension.

Authors:  C HEIDER; E DENNIS
Journal:  Ann N Y Acad Sci       Date:  1958-02-03       Impact factor: 5.691

2.  Some effects of chlorothiazide on electrolyte metabolism and its use in edematous states.

Authors:  J H LARAGH
Journal:  Ann N Y Acad Sci       Date:  1958-02-03       Impact factor: 5.691

3.  Chlorothiazide: a new type of drug for the treatment of arterial hypertension.

Authors:  W HOLLANDER; R W WILKINS
Journal:  BMQ       Date:  1957-09

4.  Enhanced effectiveness of ganglion-blocking agents in hypertensive patients during administration of a saluretic agent (chlorothiazide).

Authors:  F A TAPIA; H P DUSTAN; R A SCHNECKLOTH; A C CORCORAN; I H PAGE
Journal:  Lancet       Date:  1957-10-26       Impact factor: 79.321

5.  Effect of chlorothiazide on the hypotensive action of mecamylamine and on its urinary excretion.

Authors:  M HARINGTON; P KINCAID-SMITH
Journal:  Lancet       Date:  1958-02-22       Impact factor: 79.321

6.  The uric acid concentration in serum determined by enzymatic spectrophotometry.

Authors:  S GJORUP; H POULSEN; E PRAETORIUS
Journal:  Scand J Clin Lab Invest       Date:  1955       Impact factor: 1.713

7.  Enzymatic determination of uric acid; with detailed directions.

Authors:  E PRAETORIUS; H POULSEN
Journal:  Scand J Clin Lab Invest       Date:  1953       Impact factor: 1.713

8.  Clinical and laboratory observations on chlorothiazide (diuril), an orally effective non-mercurial diuretic agent.

Authors:  R V FORD; J H MOYER; C L SPURR
Journal:  AMA Arch Intern Med       Date:  1957-10

9.  Treatment of essential hypertension with chlorothiazide (diuril); its use alone and combined with other antihypertensive agents.

Authors:  E D FREIS; A WANKO; I M WILSON; A E PARRISH
Journal:  J Am Med Assoc       Date:  1958-01-11
  9 in total
  7 in total

1.  Studies on a new diuretic: chlorthalidone.

Authors:  I DYRDA; C DUFAULT; J G HERBERT; G TREMBLAY; J GENEST
Journal:  Can Med Assoc J       Date:  1962-03-17       Impact factor: 8.262

2.  Use of spironolactone and hydrochlorothiazide in treatment of oedema.

Authors:  R O FARRELLY; R N HOWIE; J D NORTH
Journal:  Br Med J       Date:  1960-07-30

3.  Some short-term metabolic effects of chlorothiazide in hypertensives on a rice diet.

Authors:  A RAPOPORT; B M EVANS; H WONG
Journal:  Can Med Assoc J       Date:  1959-12-15       Impact factor: 8.262

4.  [Disorders of water-electrolyte metabolism in diuretic therapy].

Authors:  H JAHRMAERKER
Journal:  Klin Wochenschr       Date:  1960-04-15

5.  Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).

Authors:  I S Salti; M Stiefel; J L Ruse; J C Laidlaw
Journal:  Can Med Assoc J       Date:  1969-07-12       Impact factor: 8.262

6.  Quantitative comparison of aldosterone antagonists in normal human subjects: prediction of therapeutic potency.

Authors:  G T McInnes; I R Harrison; J R Shelton; R M Perkins
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

7.  Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.

Authors:  J J Brown; D L Davies; J B Ferriss; R Fraser; E Haywood; A F Lever; J I Robertson
Journal:  Br Med J       Date:  1972-06-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.